Comparing removal of biopsy tract during sarcoma surgery
Part of Cancer clinical trials.
This study compares two surgical approaches for treating sarcoma in the arm or leg. It tests whether removing the needle biopsy tract (the path of the biopsy needle) along with the tumor lowers the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or strongly suspected sarcoma (a type of cancer) in an arm or leg.
- You are able to have limb-sparing surgery, meaning the tumor can be removed without amputating the limb.
- You are at least 5 years old.
- You are generally well enough to participate (ECOG performance status 0-2).
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This study looks at tissue (samples taken during diagnosis or treatment) to learn new biological and molecular clues about soft-tissue sarcoma. Participating mainly helps researchers collect usable tissue that would otherwise be discarded.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This Phase 2 trial tests a “prehabilitation” program done before surgery to help people with arm or leg (limb) sarcoma be better prepared for their operation. It may help improve how well patients tolerate treatment and recover by planning supportive care around the weeks before surgery.
This trial tests a special care plan before, during, and after surgery to lower the risk of problems for people with sarcoma. It compares this new approach to standard care for 300 patients.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.